Hospital
Ouachita County Medical Center
Ouachita County Medical Center was paid $2.73M by Medicaid between Jan 2018 and Dec 2024, across 129 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 10% of everything it billed.
33Billing provider infoOUACHITA COUNTY MEDICAL CENTER
CAMDEN, AR 71701
CAMDEN, AR 71701
33aNPI1245284769assigned 05/20/2006
33bProvider typeRural Acute Care Hospital
28Total paid$2.73M
24GClaims134,524
24DCodes billed129
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,955 | $319K | |
| 2019 | 23,730 | $470K | |
| 2020 | 18,951 | $380K | |
| 2021 | 21,153 | $630K | |
| 2022 | 18,467 | $365K | |
| 2023 | 16,834 | $340K | |
| 2024incomplete | 15,434 | $227K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10% | 3,961 | 3,005 | $277K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 8.4% | 1,027 | 917 | $228K |
| 70450 | Computed tomography, head or brain; without contrast material | 7.9% | 2,265 | 2,023 | $217K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.6% | 5,889 | 5,003 | $180K |
| 80053 | Comprehensive metabolic panel | 6.3% | 10,619 | 8,803 | $171K |
| A0425 | Ground mileage, per statute mile | 6.0% | 3,134 | 1,918 | $164K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.7% | 1,168 | 1,044 | $156K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.3% | 2,985 | 767 | $118K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.0% | 15,044 | 11,949 | $110K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.4% | 1,915 | 1,575 | $65K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.4% | 916 | 816 | $65K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.2% | 4,511 | 3,693 | $59K |
117 more codes
| A0427 | Emergency ambulance ride, advanced life support | 2.0% | 2,259 | $54K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 4,755 | $52K |
| 87486 | 1.8% | 1,103 | $48K | |
| 87581 | 1.7% | 1,083 | $47K | |
| 71045 | Radiologic examination, chest; single view | 1.5% | 4,313 | $40K |
| 87252 | 1.3% | 1,287 | $37K | |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 1,969 | $36K |
| 99284 | Emergency room visit (serious) | 1.2% | 1,231 | $32K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 616 | $31K |
| 87400 | <1% | 2,177 | $22K | |
| 84484 | <1% | 2,506 | $22K | |
| 81025 | <1% | 2,279 | $19K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 342 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,404 | $18K |
| 87276 | <1% | 1,686 | $17K | |
| 86901 | <1% | 751 | $17K | |
| 83880 | <1% | 728 | $17K | |
| 80061 | Lipid panel | <1% | 1,573 | $17K |
| 87275 | <1% | 1,548 | $17K | |
| 81003 | <1% | 5,925 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 495 | $14K |
| 83690 | <1% | 2,004 | $14K | |
| 83735 | <1% | 2,412 | $13K | |
| 0011A | <1% | 530 | $13K | |
| 82552 | <1% | 1,061 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,183 | $12K |
| 97001 | <1% | 248 | $12K | |
| 81001 | <1% | 2,700 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,112 | $10K |
| 80050 | General health panel | <1% | 241 | $10K |
| 83986 | <1% | 2,229 | $9K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 188 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 794 | $9K |
| 83605 | <1% | 506 | $9K | |
| 87186 | <1% | 1,400 | $9K | |
| 87430 | <1% | 714 | $8K | |
| 99285 | Emergency room visit (most serious) | <1% | 401 | $8K |
| 87420 | <1% | 741 | $8K | |
| 87040 | <1% | 429 | $8K | |
| 82565 | <1% | 646 | $7K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,907 | $6K |
| 82077 | <1% | 381 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 41 | $6K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 30 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 430 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 421 | $5K |
| 86756 | <1% | 295 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 184 | $5K |
| 87088 | <1% | 720 | $5K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 331 | $5K |
| 82553 | <1% | 531 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 160 | $5K |
| 85610 | <1% | 1,404 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 78 | $4K |
| 82550 | <1% | 682 | $4K | |
| 82948 | <1% | 915 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,842 | $4K |
| 71020 | <1% | 272 | $4K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 253 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 638 | $3K |
| 85730 | <1% | 690 | $3K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 14 | $3K |
| 80179 | <1% | 142 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 15 | $3K |
| 73610 | <1% | 162 | $2K | |
| 86900 | <1% | 769 | $2K | |
| 76801 | <1% | 55 | $2K | |
| 73630 | <1% | 86 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 118 | $2K |
| 84703 | <1% | 164 | $2K | |
| 86850 | <1% | 489 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 42 | $1K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 47 | $1K |
| 71010 | <1% | 194 | $1K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 26 | $1K |
| 0071A | <1% | 15 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 32 | $1K |
| 73130 | <1% | 47 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 33 | $923.94 |
| 0225U | <1% | 40 | $835.31 | |
| 97602 | <1% | 22 | $812.10 | |
| 84520 | <1% | 200 | $681.48 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 32 | $675.88 |
| 0064A | <1% | 48 | $501.60 | |
| 82570 | <1% | 82 | $487.08 | |
| 82950 | <1% | 68 | $470.81 | |
| 84702 | <1% | 36 | $369.28 | |
| 73560 | <1% | 15 | $350.20 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 84 | $347.31 |
| 82945 | <1% | 45 | $294.22 | |
| 73030 | <1% | 19 | $284.81 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 216 | $274.64 |
| 82043 | <1% | 50 | $273.56 | |
| 74018 | <1% | 14 | $255.28 | |
| 0002A | <1% | 28 | $221.60 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 119 | $211.54 |
| 0012A | <1% | 107 | $181.60 | |
| 84439 | <1% | 16 | $165.00 | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 15 | $161.18 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 636 | $149.13 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 444 | $124.81 |
| 86140 | <1% | 19 | $105.46 | |
| 85651 | <1% | 18 | $72.35 | |
| 82150 | <1% | 12 | $67.32 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 110 | $60.39 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 29 | $48.78 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 48 | $45.96 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 45 | $33.82 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 26 | $23.20 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 32 | $19.29 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 16 | $1.12 |
| 91307 | <1% | 39 | $0.28 | |
| 91306 | <1% | 33 | $0.04 | |
| G0378 | Hospital observation service, per hour | 0% | 57 | $0.00 |
| 0001A | 0% | 13 | $0.00 | |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 0% | 21 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERS, ROBERT (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ouachita County Medical Center | Camden, AR | $1.69M |
| Ouachita County Medical Center | Camden, AR | $584K |
| Ouachita County Medical Center | Camden, AR | $313K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.